Misook Yu

Array ( [id] => 7206060 [patent_doc_number] => 20050043224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy' [patent_app_type] => utility [patent_app_number] => 10/881028 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14036 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043224.pdf [firstpage_image] =>[orig_patent_app_number] => 10881028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7419616 [patent_doc_number] => 20040228925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method for inducing an anti-tumor and anti-cachexia immune response in mammals' [patent_app_type] => new [patent_app_number] => 10/871340 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5901 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228925.pdf [firstpage_image] =>[orig_patent_app_number] => 10871340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5084897 [patent_doc_number] => 20070274948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Methods of Therapy for Chronic Lymphocytic Leukemia' [patent_app_type] => utility [patent_app_number] => 10/566410 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26114 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274948.pdf [firstpage_image] =>[orig_patent_app_number] => 10566410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101446 [patent_doc_number] => 07727533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Serpentine transmembrane antigens expressed in human cancers and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/857785 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 44 [patent_no_of_words] => 22204 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727533.pdf [firstpage_image] =>[orig_patent_app_number] => 10857785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983235 [patent_doc_number] => 20050153305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Novel proteins and nucleic acids encoding same' [patent_app_type] => utility [patent_app_number] => 10/851438 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51216 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153305.pdf [firstpage_image] =>[orig_patent_app_number] => 10851438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177685 [patent_doc_number] => 07655393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Adoptive immune cells for tumor vaccines' [patent_app_type] => utility [patent_app_number] => 11/579280 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8741 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655393.pdf [firstpage_image] =>[orig_patent_app_number] => 11579280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422151 [patent_doc_number] => 20040229267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Tumor suppressor pathway in C. elegans' [patent_app_type] => new [patent_app_number] => 10/839896 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17654 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229267.pdf [firstpage_image] =>[orig_patent_app_number] => 10839896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910661 [patent_doc_number] => 07329743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Gene encoding labyrinthin, a marker for cancer' [patent_app_type] => utility [patent_app_number] => 10/830702 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8231 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329743.pdf [firstpage_image] =>[orig_patent_app_number] => 10830702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202529 [patent_doc_number] => 20050042631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Cloning and characterization of two novel m-RNA transcription factors' [patent_app_type] => utility [patent_app_number] => 10/819860 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28961 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042631.pdf [firstpage_image] =>[orig_patent_app_number] => 10819860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759624 [patent_doc_number] => 20060210569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Antibodies inhibiting transportation activity of peptide transporter' [patent_app_type] => utility [patent_app_number] => 10/550987 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6243 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210569.pdf [firstpage_image] =>[orig_patent_app_number] => 10550987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7191724 [patent_doc_number] => 20040204574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'TSA305 gene' [patent_app_type] => new [patent_app_number] => 10/800911 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6614 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204574.pdf [firstpage_image] =>[orig_patent_app_number] => 10800911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7442331 [patent_doc_number] => 20040163137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'PG-3 and biallelic markers thereof' [patent_app_type] => new [patent_app_number] => 10/468582 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 86366 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20040163137.pdf [firstpage_image] =>[orig_patent_app_number] => 10468582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154267 [patent_doc_number] => 20070037150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Tyrosine kinome' [patent_app_type] => utility [patent_app_number] => 10/544536 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4879 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037150.pdf [firstpage_image] =>[orig_patent_app_number] => 10544536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5858759 [patent_doc_number] => 20060228710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Novel therapeutic targets in cancer' [patent_app_type] => utility [patent_app_number] => 10/545777 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 82002 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228710.pdf [firstpage_image] =>[orig_patent_app_number] => 10545777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732284 [patent_doc_number] => 20060257401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Sensitizing cells for apoptosis by selectively blocking cytokines' [patent_app_type] => utility [patent_app_number] => 10/544794 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15662 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257401.pdf [firstpage_image] =>[orig_patent_app_number] => 10544794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308770 [patent_doc_number] => 20040142395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways' [patent_app_type] => new [patent_app_number] => 10/770725 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23056 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142395.pdf [firstpage_image] =>[orig_patent_app_number] => 10770725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153926 [patent_doc_number] => 20070036809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Tolerance-induced targeted antibody production' [patent_app_type] => utility [patent_app_number] => 10/542586 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17331 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036809.pdf [firstpage_image] =>[orig_patent_app_number] => 10542586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386298 [patent_doc_number] => 20040180371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions of a novel serine protease inhibitor' [patent_app_type] => new [patent_app_number] => 10/766778 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 63554 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180371.pdf [firstpage_image] =>[orig_patent_app_number] => 10766778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010259 [patent_doc_number] => 20050063975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/752421 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21515 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20050063975.pdf [firstpage_image] =>[orig_patent_app_number] => 10752421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 52232 [patent_doc_number] => 07771723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Remedies for myeloma to be used together with nitrogen mustard antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/749538 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 12749 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771723.pdf [firstpage_image] =>[orig_patent_app_number] => 10749538 [rel_patent_id] =>[rel_patent_doc_number] =>)